Takotsubo Syndrome in Patients With COVID-19: A Systematic Review

Pharmacology, Toxicology and Pharmaceutical Science

• Infection 100%
• Takotsubo Cardiomyopathy 100%
• Coronavirinae 100%
• Diseases 100%
• Respiratory Tract Disease 23%
• Acute Respiratory Tract Disease 15%
• Mortality Rate 7%
• Coughing 3%
• Pathophysiology 3%
• Cardiovascular Risk 3%
• Dyspnea 3%
• Catecholamine 3%
• Thorax Pain 3%

Keyphrases

• COVID-19 100%
• Takotsubo Syndrome 100%
• Coronavirus Disease (COVID) 28%
• Respiratory Disease 24%
• Acute Respiratory Distress Syndrome 16%
• Disease Groups 8%
• Pneumonia 4%
• Clinical Outcomes 4%
• Cough 4%
• High Mortality Rate 4%
• Cardiovascular Risk 4%
• Worse Outcome 4%
• Clinical Data 4%
• Mortality Rate 4%
• Chest Pain 4%
• Catecholamines 4%
• PubMed 4%
• Embase 4%
• Dyspnea 4%
• Cochrane Library 4%
• Library Databases 4%
• Direct Therapy 4%
• Respiratory Conditions 4%
• Cardioprotective Medications 4%
• Physical Trigger 4%
• Apical Ballooning 4%
• Segment Type 4%
• Basal Segment 4%